Activity

Activity ID

13661

Expires

July 1, 2027

Format Type

Journal-based

CME Credit

1

Fee

$30

CME Provider: AMA Journal of Ethics

Description of CME Course

Severe opioid withdrawal, risk of patient-initiated discharge, and some inpatients’ use of unregulated substances prompt clinical and ethical questions considered in this commentary on a case. Short-acting opioids can be used to manage inpatients’ pain and opioid use disorder (OUD) withdrawal symptoms. Including evidence-based interventions such as naloxone kits, substance use equipment, and supervised consumption in some inpatients’ care plans may make those patients safer and reduce their risk of death. These and other strategies align with clinicians’ ethical duties to minimize harms and maximize benefits for inpatients with OUD.

Disclaimers

1. This activity is accredited by the American Medical Association.
2. This activity is free to AMA members.

Register for this Activity

ABMS Member Board Approvals by Type
More Information
Commercial Support?
No

NOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.

Educational Objectives

1. Explain a new or unfamiliar viewpoint on a topic of ethical or professional conduct
2. Evaluate the usefulness of this information for health care practice, teaching, or conduct
3. Decide whether and when to apply the new information to health care practice, teaching, or conduct

Keywords

Ethics, Opioids, Substance Use and Addiction Medicine

Competencies

Medical Knowledge, Professionalism

CME Credit Type

AMA PRA Category 1 Credit

DOI

10.1001/amajethics.2024.512

View All Activities by this CME Provider

The information provided on this page is subject to change. Please refer to the CME Provider’s website to confirm the most current information.